Most striking was our discovery that, while all treatments tested reduced the number of pulmonary granulomas, the R+PDP treatment was better able to reduce the percent of lung tissue affected by necrosis and resolve necrotic granulomas than other treatments. Here, PDP1 is linked to Granuloma.